Results for tag: "Paromomycin"

Paromomycin is an antibiotic used to treat a variety of bacterial infections. It is a member of the aminoglycoside class of antibiotics, which are derived from Streptomyces bacteria. Paromomycin is effective against a wide range of Gram-positive and Gram-negative bacteria, including Escherichia coli, Salmonella, Shigella, and Klebsiella. It is also used to treat protozoal infections, such as amebiasis and giardiasis. Paromomycin is available in both oral and injectable forms, and is often used in combination with other antibiotics. Paromomycin is widely used in the treatment of bacterial infections, and is often prescribed in combination with other antibiotics. It is generally well-tolerated, with few side effects. However, it can cause nephrotoxicity and ototoxicity, and should be used with caution in patients with renal or auditory impairment. Companies in the paromomycin market include Merck & Co., Inc., Pfizer, Inc., Sanofi, and GlaxoSmithKline plc. Show Less Read more